Travere Therapeutics Inc

+0.31 (+1.23%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.57B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$50.09 Million
Adjusted EPS-$0.46
See more estimates
10-Day MAN/A
50-Day MAN/A
200-Day MAN/A
See more pivots

Travere Therapeutics, Inc. Stock, NASDAQ:TVTX

3611 Valley Centre Drive, Suite 300, San Diego, California 92130
United States of America
Phone: +1.888.969.7879
Number of Employees: 221


Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. Its products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 8, 2008 and is headquartered in San Diego, CA.